Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

241.52 -0.52 (-0.21%)
Official Closing Price Updated: 7:00 PM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,415,542
Open 244.21
Bid (Size) 241.00 (100)
Ask (Size) 245.75 (100)
Prev. Close 242.04
Today's Range 241.50 - 245.59
52wk Range 141.50 - 251.71
Shares Outstanding 2,628,679,824
Dividend Yield 2.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Johnson & Johnson’s Trial In Early-Stage Bladder Cancer Yield Positive Safety Results ↗
The study also demonstrated complete and durable responses in patients with recurrent intermediate-risk disease, along with encouraging recurrence-free outcomes in high-risk disease, the company said. 
Via Stocktwits
News headline image
Flight to Quality: JPMorgan and Eli Lilly Emerge as Defensive Anchors Amid Geopolitical Storm
In a day marked by heightened global tensions and a sharp spike in energy prices, the U.S. equity markets witnessed a decisive "Great Rotation" as investors abandoned high-growth technology names in... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks

Performance

YTD
+16.5%
+16.5%
1 Month
+0.3%
+0.3%
3 Month
+14.2%
+14.2%
6 Month
+35.6%
+35.6%
1 Year
+48.2%
+48.2%

More News

Read More
News headline image
The Best Dividend Stocks to Buy and Hold Forever ↗
Via The Motley Fool
Topics Intellectual Property
Johnson & Johnson (NYSE:JNJ): A Dividend King Built for Sustainable Passive Income ↗
Via Chartmill
News headline image
1 No-Brainer S&P 500 Vanguard ETF to Buy Right Now for Less Than $1,000 ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)
Via Finterra
Topics ETFs Intellectual Property
News headline image
Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients
From Johnson & Johnson
Via Business Wire
News headline image
End of an Era: West Pharmaceutical Shares Slide as Longtime CEO Eric Green Announces Retirement
Via MarketMinute
Topics Economy Retirement
News headline image
Cracks in the Bull Case: S&P 500 Breaches Key Support as Institutional Distribution Takes Hold
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Safe Haven in a Storm: Healthcare Leads Markets as Geopolitical Tensions Spark Defensive Rotation
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Quiet Outperformance From an Overlooked Dividend ETF ↗
Via MarketBeat
News headline image
2 No-Brainer Dividend Stocks to Buy in 2026 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
These 7 Elite Dividend Stocks Pay $114 Billion Annually, Combined, to Their Shareholders ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
FDA Clears Johnson & Johnson's Multiple Myeloma Combo Drug After Strong Survival Results ↗
Via Benzinga
News headline image
Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion
Via FinancialNewsMedia
News headline image
2 Top Defensive ETFs That Prioritize Stability Over Excitement ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs World Trade
News headline image
ImmunityBio (IBRX) Shares Plummet Despite Piper Sandler Price Target Hike and 700% Revenue Growth
Via MarketMinute
Topics Earnings Economy
News headline image
The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
From Johnson & Johnson
Via Business Wire
News headline image
How to Spot Winning Innovation ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Middleby Is Spinning Off Its Food Processing Segment After a $540 Million Asset Sale. Can the Breakup Close Its Valuation Gap? ↗
Via The Motley Fool
News headline image
2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash ↗
Via The Motley Fool
News headline image
Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability
Via Finterra
Topics Earnings Economy Intellectual Property
News headline image
ACR Alpine Capital Research Buys 1 Million Shares of Arrow Electronics Stock ↗
Via The Motley Fool
News headline image
Boring Is Beautiful: Why Johnson & Johnson Is Beating the Tech Sector ↗
Via MarketBeat

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 241.52
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 03/13/26 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 634.88B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 635B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.